$15SEPTEMBER 16 - 2022HEALTHCARETECHOUTLOOK.COMISSN 2691 - 3933OncoGenomXOncoGenomXUSHERING-IN A NEW ERA IN BREAST CANCER TREATMENTONCOLOGYEDITIONHEALTHCARE TECHNOLOGY KNOWLEDGE NETWORKEUROPE SPECIALWolfgang Hackl, CEODavid Demanse, CSO
Page 2 >